Want to join the conversation?
$ENDP's revenue from U.S. Generic Pharmaceuticals for 4Q15 jumped 81% to $609MM from last year, on growth from addition of sales from acquisition of Par Pharmaceutical, as well as underlying growth of certain products. Revenue from International Pharmaceuticals rose 7% to $85MM on sales growth in Mexico.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!